Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Concurrent Nab-paclitaxel/Carboplatin and Thoracic Radiotherapy in Inoperable Stage III Squamous Cell Lung Cancer
NCT03802058Phase 2Terminated
- Sponsor
- Wuhan University
- Start
- Mar 2019
- Primary completion
- Dec 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of paclitaxel in squamous cell carcinoma of the lung (LSCC), sponsored by Wuhan University. Started Mar 2019; status: terminated.
02
Drugs
paclitaxel
03
Conditions
squamous cell carcinoma of the lung (LSCC)
Beyond the preview
Go deeper on NCT03802058.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03802058.